Skip to main content

CORRECTION article

Front. Med., 27 January 2023
Sec. Gastroenterology
Volume 9 - 2022 | https://doi.org/10.3389/fmed.2022.1091788

Corrigendum: Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy

This article is a correction to:

  1. Compositional Quality and Potential Gastrointestinal Behavior of Probiotic Products Commercialized in Italy

    1. Read original article
\nAlessandra VecchioneAlessandra Vecchione1Francesco CelandroniFrancesco Celandroni1Diletta MazzantiniDiletta Mazzantini1Sonia SenesiSonia Senesi2Antonella LupettiAntonella Lupetti1Emilia Ghelardi, Emilia Ghelardi1,3*
  • 1Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
  • 2Department of Biology, University of Pisa, Pisa, Italy
  • 3Research Center Nutraceuticals and Food for Health-Nutrafood, University of Pisa, Pisa, Italy

A corrigendum on
Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy

by Vecchione, A., Celandroni, F., Mazzantini, D., Senesi, S., Lupetti, A., and Ghelardi, E. (2018). Front. Med. 5:59. doi: 10.3389/fmed.2018.00059

In the published article, there was an error in Table 2 as published. The total CFU of VSL3 in Table 2 was displayed as “4.53 ± 0.47 × 1013.” The correct total CFU of VSL3 is “4.53 ± 0.47 × 1012.” The total CFU of Codex in Table 2 was displayed as “2.68 ± 2.4 × 109.” The correct total CFU of Codex is “2.68 ± 2.40 × 109.” The corrected Table 2 and its caption appear below.

TABLE 2
www.frontiersin.org

Table 2. Enumeration of the organisms contained in a unit dose of each probiotic formulation.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: probiotics, microbial identification, MALDI-TOF, gastric juice, intestinal fluid, acid resistance, bile tolerance

Citation: Vecchione A, Celandroni F, Mazzantini D, Senesi S, Lupetti A and Ghelardi E (2023) Corrigendum: Compositional quality and potential gastrointestinal behavior of probiotic products commercialized in Italy. Front. Med. 9:1091788. doi: 10.3389/fmed.2022.1091788

Received: 07 November 2022; Accepted: 30 November 2022;
Published: 27 January 2023.

Edited and reviewed by: Angel Lanas, University of Zaragoza, Spain

Copyright © 2023 Vecchione, Celandroni, Mazzantini, Senesi, Lupetti and Ghelardi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Emilia Ghelardi, yes ZW1pbGlhLmdoZWxhcmRpJiN4MDAwNDA7bWVkLnVuaXBpLml0

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.